Neogen (NEOG) Total Non-Current Liabilities (2011 - 2026)
Neogen's (NEOG) quarterly Total Non-Current Liabilities came in at $1.2 billion in Q1 2026, down 8.99% year-on-year from $1.3 billion in Q1 2025, and little changed quarter-over-quarter from $1.2 billion in Q4 2025.
Neogen (NEOG) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Neogen's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 8.99% year-over-year to $1.2 billion in Q1 2026; TTM through Feb 2026 was $1.2 billion, a 8.99% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 2.9% from the prior year.
- Total Non-Current Liabilities steadied at $1.2 billion in Q1 2026 per NEOG's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $1.4 billion in Q4 2022 and bottomed at $83.0 million in Q3 2022.
- The 5-year median for Total Non-Current Liabilities is $1.3 billion (2025), against an average of $1.1 billion.
- Across the five-year window, Total Non-Current Liabilities surged 1630.7% in 2022 and slipped 9.64% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $1.4 billion in 2022, then declined by 1.54% to $1.4 billion in 2023, then declined by 5.29% to $1.3 billion in 2024, then fell by 9.64% to $1.2 billion in 2025, then slipped by 0.07% to $1.2 billion in 2026.
- Per Business Quant, the three latest NEOG Total Non-Current Liabilities figures stand at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 3.53 Bn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | 24.21 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | 3.57 Bn |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 9.85 Bn |
| 10 | Neogen | 2.06 Bn | 1.90 Bn | 99.00 Mn | 1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.21 Bn |
| Nov 30, 2025 | 1.21 Bn |
| Aug 31, 2025 | 1.22 Bn |
| May 31, 2025 | 1.33 Bn |
| Feb 28, 2025 | 1.33 Bn |
| Nov 30, 2024 | 1.34 Bn |
| Aug 31, 2024 | 1.33 Bn |
| May 31, 2024 | 1.37 Bn |
| Feb 29, 2024 | 1.40 Bn |
| Nov 30, 2023 | 1.42 Bn |
| Aug 31, 2023 | 1.38 Bn |
| May 31, 2023 | 1.38 Bn |
| Feb 28, 2023 | 1.35 Bn |
| Nov 30, 2022 | 1.44 Bn |
| Aug 31, 2022 | 82.95 Mn |
| May 31, 2022 | 94.86 Mn |
| Feb 28, 2022 | 86.91 Mn |
| Nov 30, 2021 | 83.25 Mn |
| Aug 31, 2021 | 72.59 Mn |
| May 31, 2021 | 75.52 Mn |